Cargando…

Discovery and Structure–Activity Relationship Studies of Novel Adenosine A(1) Receptor-Selective Agonists

[Image: see text] A series of benzyloxy and phenoxy derivatives of the adenosine receptor agonists N(6)-cyclopentyl adenosine (CPA) and N(6)-cyclopentyl 5′-N-ethylcarboxamidoadenosine (CP-NECA) were synthesized, and their potency and selectivity were assessed. We observed that the most potent were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Preti, Barbara, Suchankova, Anna, Deganutti, Giuseppe, Leuenberger, Michele, Barkan, Kerry, Manulak, Iga, Huang, Xianglin, Carvalho, Sabrina, Ladds, Graham, Lochner, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661479/
https://www.ncbi.nlm.nih.gov/pubmed/36270633
http://dx.doi.org/10.1021/acs.jmedchem.2c01414
Descripción
Sumario:[Image: see text] A series of benzyloxy and phenoxy derivatives of the adenosine receptor agonists N(6)-cyclopentyl adenosine (CPA) and N(6)-cyclopentyl 5′-N-ethylcarboxamidoadenosine (CP-NECA) were synthesized, and their potency and selectivity were assessed. We observed that the most potent were the compounds with a halogen in the meta position on the aromatic ring of the benzyloxy- or phenoxycyclopentyl substituent. In general, the NECA-based compounds displayed greater A(1)R selectivity than the adenosine-based compounds, with N(6)-2-(3-bromobenzyloxy)cyclopentyl-NECA and N(6)-2-(3-methoxyphenoxy)cyclopentyl-NECA showing ∼1500-fold improved A(1)R selectivity compared to NECA. In addition, we quantified the compounds’ affinity and kinetics of binding at both human and rat A(1)R using a NanoBRET binding assay and found that the halogen substituent in the benzyloxy- or phenoxycyclopentyl moiety seems to confer high affinity for the A(1)R. Molecular modeling studies suggested a hydrophobic subpocket as contributing to the A(1)R selectivity displayed. We believe that the identified selective potent A(1)R agonists are valuable tool compounds for adenosine receptor research.